These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1350614)

  • 21. Ecstasy--dental implications.
    Duxbury AJ
    Br Dent J; 1993 Jul; 175(1):38. PubMed ID: 8101450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ecstasy and dantrolene.
    Barrett PJ
    BMJ; 1992 Nov; 305(6863):1225. PubMed ID: 1361389
    [No Abstract]   [Full Text] [Related]  

  • 23. Methylenedioxyamphetamine ('Ecstasy') associated keratopathy.
    O'Neill D; Dart JK
    Eye (Lond); 1993; 7 ( Pt 6)():805-6. PubMed ID: 7907032
    [No Abstract]   [Full Text] [Related]  

  • 24. Catatonic stupor after "ecstasy".
    Lee JW
    BMJ; 1994 Mar; 308(6930):717-8. PubMed ID: 7908237
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of 'ecstasy' overdose with dantrolene.
    Stone RJ
    Anaesthesia; 1993 Jan; 48(1):83. PubMed ID: 8094606
    [No Abstract]   [Full Text] [Related]  

  • 26. Ecstasy and neurodegeneration. Tablets often contain substances in addition to, or instead of, ecstasy..
    Winstock AR; King LA
    BMJ; 1996 Aug; 313(7054):423-4. PubMed ID: 8761240
    [No Abstract]   [Full Text] [Related]  

  • 27. Hyponatraemia after ingestion of ecstasy.
    Kessel B
    BMJ; 1994 Feb; 308(6925):414. PubMed ID: 7907245
    [No Abstract]   [Full Text] [Related]  

  • 28. 'Ecstasy': a human neurotoxin?
    Peroutka SJ
    Arch Gen Psychiatry; 1989 Feb; 46(2):191. PubMed ID: 2563326
    [No Abstract]   [Full Text] [Related]  

  • 29. 'Ecstasy' misuse--overdose or normal dose?
    Barrett PJ
    Anaesthesia; 1993 Jan; 48(1):83. PubMed ID: 8094605
    [No Abstract]   [Full Text] [Related]  

  • 30. Chronic paranoid psychosis after misuse of MDMA ("ecstasy").
    McGuire P; Fahy T
    BMJ; 1991 Mar; 302(6778):697. PubMed ID: 1673631
    [No Abstract]   [Full Text] [Related]  

  • 31. Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") may be separable from its neurotoxic actions: clinical evidence.
    McCann UD; Ricaurte GA
    J Clin Psychopharmacol; 1993 Jun; 13(3):214-7. PubMed ID: 8102623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Entactogenic drugs "ecstasy" (MDMA), "eve" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?].
    Tretter F
    Nervenarzt; 1997 Nov; 68(11):922-3. PubMed ID: 9732739
    [No Abstract]   [Full Text] [Related]  

  • 33. Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA.
    Rattray M
    Essays Biochem; 1991; 26():77-87. PubMed ID: 1685707
    [No Abstract]   [Full Text] [Related]  

  • 34. Hyponatraemia and catatonic stupor after taking "ecstasy".
    Maxwell DL; Polkey MI; Henry JA
    BMJ; 1993 Nov; 307(6916):1399. PubMed ID: 7903884
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity.
    Brodkin J; Malyala A; Nash JF
    Pharmacol Biochem Behav; 1993 Jul; 45(3):647-53. PubMed ID: 8101380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ecstasy--a dangerous drug.
    Teggin AF
    S Afr Med J; 1992 Apr; 81(8):431-2. PubMed ID: 1348879
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of MDMA neurotoxicity upon its conditioned place preference and discrimination.
    Schechter MD
    Pharmacol Biochem Behav; 1991 Mar; 38(3):539-44. PubMed ID: 1676847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New doves, a new legal high?
    Herbert J; Tracey JA
    Ir Med J; 2010 Mar; 103(3):92-3. PubMed ID: 20666079
    [No Abstract]   [Full Text] [Related]  

  • 39. Neurotoxicity of MDMA: neurochemical effects.
    Schmidt CJ; Kehne JH
    Ann N Y Acad Sci; 1990; 600():665-80; discussion 680-1. PubMed ID: 1979217
    [No Abstract]   [Full Text] [Related]  

  • 40. Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat.
    Hekmatpanah CR; McKenna DJ; Peroutka SJ
    Neurosci Lett; 1989 Sep; 104(1-2):178-82. PubMed ID: 2573011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.